Grace Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $8 | $0 | $0 |
Gross Profit | -2 | 5 | -2 | -2 |
EBITDA | -3,360 | -3,181 | -3,702 | -4,829 |
EBIT | -3,362 | -3,183 | -3,704 | -4,831 |
Net Income | -3,362 | 636 | -4,155 | -3,432 |
Net Change In Cash | 0 | 8 | 0 | 0 |
Free Cash Flow | -1,801 | -2,954 | -4,115 | -4,239 |
Cash | 20,005 | 22,133 | 11,055 | 15,155 |
Basic Shares | 15,924 | 13,718 | 11,506 | 11,506 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7 | -11 | -124 | 0 |
EBITDA | -12,760 | -11,327 | -18,123 | -15,340 |
EBIT | -12,767 | -11,338 | -18,247 | -15,589 |
Net Income | -12,767 | -12,853 | -42,429 | -9,819 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,904 | -12,355 | -15,930 | -17,234 |
Cash | 22,133 | 23,005 | 27,875 | 30,339 |
Basic Shares | 12,087 | 7,436 | 7,435 | 6,140 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.28 |
2025-03-31 | $0.13 |
2024-12-31 | -$0.51 |
2024-09-30 | -$0.41 |
